Actrii proteins and uses thereof
Номер патента: EP4351626A2
Опубликовано: 17-04-2024
Автор(ы): Gang Li, Patrick Andre, Ravindra Kumar
Принадлежит: Acceleron Pharma Inc
Опубликовано: 17-04-2024
Автор(ы): Gang Li, Patrick Andre, Ravindra Kumar
Принадлежит: Acceleron Pharma Inc
Реферат: In some aspects, the disclosure relates to compositions and methods comprising ActRII polypeptides to treat, prevent, or reduce the progression rate and/or severity of pulmonary hypertension associated with lung disease (e.g, pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), or combined pulmonary fibrosis and emphysema (CPFE)), particularly treating, preventing or reducing the progression rate and/or severity of one or more pulmonary hypertension associated with lung disease (e.g., pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), or combined pulmonary fibrosis and emphysema (CPFE)) associated complications.
Sumo and uses thereof
Номер патента: US20210198327A1. Автор: Luca COLNAGHI,Luana Fioriti,Amir Levine. Владелец: Plico Biotech Inc. Дата публикации: 2021-07-01.